XML 28 R7.htm IDEA: XBRL DOCUMENT v3.3.1.900
Consolidated Statements Of Cash Flows - USD ($)
 12 Months Ended
Dec. 31, 2015
Dec. 31, 2014
Dec. 31, 2013
Cash flows provided by operating activities      
Net income $ 542,242,000 $ 686,256,000 $ 841,768,000
Adjustments to reconcile net income to net cash provided by operating activities      
Amortization, accretion and depreciation 18,179,000 47,771,000 51,596,000
Equity in undistributed earnings of other ventures (10,087,000) (19,990,000) (15,450,000)
Net realized and unrealized losses (gains) on investments 68,918,000 (41,433,000) (35,058,000)
Net unrealized losses (gains) included in net investment income 13,549,000 1,393,000 (75,789,000)
Net unrealized losses included in other income (loss) 426,000 1,612,000 12,782,000
Change in:      
Premiums receivable (105,281,000) 34,080,000 17,278,000
Prepaid reinsurance premiums (128,410,000) (28,678,000) 10,950,000
Reinsurance recoverable (64,104,000) 34,331,000 91,487,000
Deferred acquisition costs (89,241,000) (28,375,000) (29,062,000)
Reserve for claims and claim expenses (43,310,000) (151,220,000) (315,647,000)
Unearned premiums 144,040,000 34,498,000 78,371,000
Reinsurance balances payable 64,924,000 161,558,000 2,603,000
Other 2,892,000 (71,146,000) 159,892,000
Net cash provided by operating activities 414,737,000 660,657,000 795,721,000
Cash flows (used in) provided by investing activities      
Proceeds from sales and maturities of fixed maturity investments trading 9,481,742,000 7,682,573,000 8,251,405,000
Purchases of fixed maturity investments trading (9,683,068,000) (7,639,178,000) (8,466,467,000)
Proceeds from sales and maturities of fixed maturity investments available for sale 8,688,000 7,088,000 45,178,000
Net purchases of equity investments trading (147,558,000) (20,003,000) (33,055,000)
Net sales (purchases) of short term investments 669,116,000 45,023,000 (246,971,000)
Net sales of other investments 15,843,000 59,120,000 76,214,000
Net (purchases) sales of investments in other ventures (10,150,000) 1,030,000 (4,000,000)
Net sales of other assets 4,500,000 6,000,000 2,181,000
Net proceeds related to sale of discontinued operations 0 0 60,000,000
Net purchase of Platinum (678,152,000) 0 0
Net cash (used in) provided by investing activities (339,039,000) 141,653,000 (315,515,000)
Cash flows used in financing activities      
Dividends paid – RenaissanceRe common shares (53,967,000) (45,912,000) (49,267,000)
Dividends paid – preference shares (22,381,000) (22,381,000) (24,948,000)
RenaissanceRe common share repurchases (259,874,000) (514,678,000) (207,410,000)
Issuance of debt 445,589,000 0 0
Repayment of debt 0 0 (102,436,000)
Net third party redeemable noncontrolling interest share transactions (193,032,000) (111,707,000) (5,750,000)
Net cash used in financing activities (83,665,000) (694,678,000) (398,955,000)
Effect of exchange rate changes on foreign currency cash (10,732,000) 9,920,000 1,423,000
Net (decrease) increase in cash and cash equivalents (18,699,000) 117,552,000 82,674,000
Net decrease in cash and cash equivalents of discontinued operations 0 0 21,213,000
Cash and cash equivalents, beginning of period 525,584,000 408,032,000 304,145,000
Cash and cash equivalents, end of period 506,885,000 525,584,000 408,032,000
Series C Preferred Stock      
Cash flows used in financing activities      
Redemption of preference shares 0 0 (125,000,000)
Series D Preferred Stock      
Cash flows used in financing activities      
Redemption of preference shares 0 0 (150,000,000)
Series E Preferred Stock      
Cash flows used in financing activities      
Issuance of 5.375% Series E preference shares, net of expenses $ 0 $ 0 $ 265,856,000